|
|
| Titles |
1973 British Journal of Psychiatry Priadel |
| Related Item |
|
| Genre |
medicine |
| Genre |
medicines (psychiatric) |
| Identifier |
BJP1973Apr_Jun16 |
| Note |
The first controlled release preparation of lithium carbonate in the world. Priadel reduces the frequency and duration of recurrent depressive and manic-depressive episodes. Clinical trial results: Priadel prevented relapse in 86% of patients, Priadel eliminated the need for ECT, Priadel reduced the time spent in hospital from 26.9 weeks to 3.5 weeks. The majority of depressive and manic-depressive patients experience an increase in frequency and intensity of relapse with advancing age. After three or more episodes patients treated by conventional methods can expect to spend nearly half their lives incapacitated by their illness. The risk of suicide also increases and more than 15 per cent will kill themselves. Retrospective studies suggested that as many as 20 percent of 100 known suicides might have been prevented by the prophylactic use of lithium. |
| Abstract |
Lithium Carbonate, Delandale Laboratories, A series of blue and grey rectangular prisms placed in a random order in series; they start larger from the left and become smaller as they go towards the right of the page. Also an enlarged image of a Priadel tablet. |
